Income Statement Ind-Swift Laboratories Limited

Stocks

INDSWFTLAB

INE915B01019

Pharmaceuticals

Delayed NSE India S.E. Other stock markets 12:39:00 18/06/2026 +04			5-day change	1st Jan Change
167.01 ^INR	+2.79%		+5.28%	+89.46%

05-28	Ind-Swift Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
04-07	Ind Swift Laboratories says tribunal rejected all claims of PI Industries, counterclaims of co, others	RE

02f4b13bd7b3a1.jcn-dQqS4Cva1wLjgGBXjFomSMXhWgbn9RmkeWg1moA.uP_NBFz6r1KinUmgtQIP9jtNPIKQImWwhiHsDR9G8ez3u4cUcPCCQJ-bSw

Published financial data: IND-SWIFT LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	8.91B	10.39B	12.07B	12.81B	5.62B
Other Revenues, Total	154M	134M	86.24M	164M	-
Total Revenues	9.07B	10.52B	12.16B	12.97B	5.62B
Cost of Goods Sold, Total	4.51B	5.27B	6.56B	6.61B	2.88B
Gross Profit	4.55B	5.26B	5.6B	6.36B	2.74B
Selling General & Admin Expenses, Total	1.08B	1.15B	1.4B	1.58B	1.25B
Depreciation & Amortization - (IS)	873M	1.31B	574M	533M	245M
Other Operating Expenses	1.49B	1.87B	1.81B	2.09B	1.68B
Other Operating Expenses, Total	3.44B	4.33B	3.79B	4.21B	3.18B
Operating Income	1.11B	924M	1.82B	2.15B	-439M
Interest Expense, Total	-934M	-915M	-864M	-467M	-13.83M
Interest And Investment Income	5.13M	5.62M	58.72M	184M	383M
Net Interest Expenses	-928M	-909M	-805M	-283M	369M
Income (Loss) On Equity Invest.	-	-	-2.34M	-4.9M	-517K
Currency Exchange Gains (Loss)	32.72M	148M	181M	106M	103M
Other Non Operating Income (Expenses)	-33.83M	99.16M	-48.57M	-43.32M	25.36M
EBT, Excl. Unusual Items	180M	262M	1.14B	1.92B	58.2M
Gain (Loss) On Sale Of Assets	-	-65.66M	-613K	22.35M	287M
Asset Writedown	-	-71.01M	-10M	-	-
Insurance Settlements	-	-	-	-	-
Other Unusual Items	-	-	-266M	3.87B	2.23B
EBT, Incl. Unusual Items	180M	125M	863M	5.81B	2.58B
Income Tax Expense	212M	147M	387M	1.6B	72.7M
Earnings From Continuing Operations	-31.47M	-21.49M	476M	4.21B	2.5B
Net Income to Company	-31.47M	-21.49M	476M	4.21B	2.5B
Net Income - (IS)	-31.47M	-21.49M	476M	4.21B	2.5B
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-31.47M	-21.49M	476M	4.21B	2.5B
Net Income to Common Excl. Extra Items	-31.47M	-21.49M	476M	4.21B	2.5B
Per Share Items
Net EPS - Basic	-0.53	-0.36	8.06	71.24	37.25
Basic EPS - Continuing Operations	-0.53	-0.36	8.06	71.24	37.25
Basic Weighted Average Shares Outstanding	59.09M	59.09M	59.09M	59.09M	67.24M
Net EPS - Diluted	-0.53	-0.36	8.06	71.24	35.21
Diluted EPS - Continuing Operations	-0.53	-0.36	8.06	71.24	35.21
Diluted Weighted Average Shares Outstanding	59.09M	59.09M	59.09M	59.09M	71.14M
Normalized Basic EPS	1.9	2.77	12.06	20.36	0.54
Normalized Diluted EPS	1.9	2.77	12.06	20.36	0.51
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	1.66B	2.22B	2.39B	2.68B	-218M
EBITA	1.11B	924M	1.82B	2.15B	-439M
EBIT	1.11B	924M	1.82B	2.15B	-439M
EBITDAR	1.67B	2.23B	2.4B	2.69B	-201M
Total Revenues (As Reported)	9.14B	10.81B	12.41B	13.26B	6.43B
Effective Tax Rate - (Ratio)	117.48	117.15	44.84	27.58	2.82
Total Current Taxes	117M	248M	151M	1.71B	77.44M
Total Deferred Taxes	94.76M	-109M	234M	-108M	-38.23M
Normalized Net Income	113M	164M	712M	1.2B	36.38M
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	905M	886M	836M	452M	13.83M
Non-Cash Pension Expense	7.79M	8.74M	8.74M	13.39M	7.19M
Supplemental Operating Expense Items
Advertising Expense	7.66M	2.36M	34.92M	45.55M	60.16M
Selling and Marketing Expenses	7.66M	2.36M	34.92M	45.55M	60.16M
Research And Development Expense From Footnotes	330M	327M	426M	355M	23.05M
Net Rental Expense, Total	5.37M	5.16M	7.45M	8.64M	16.35M
Imputed Operating Lease Interest Expense	3.94M	3.85M	5.67M	7.34M	1.4M
Imputed Operating Lease Depreciation	1.43M	1.3M	1.78M	1.29M	14.95M
Maintenance & Repair Expenses, Total	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	-	-	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	116M	215M	182M	4.32B	4.28B
Short Term Investments	-	-	-	-	394M
Total Cash And Short Term Investments	116M	215M	182M	4.32B	4.67B
Accounts Receivable, Total	4.32B	4.55B	5.05B	1.69B	1.65B
Other Receivables	458M	392M	250M	90.98M	407M
Notes Receivable	-	-	968M	1.7M	5.16M
Total Receivables	4.78B	4.94B	6.27B	1.78B	2.06B
Inventory	3.76B	4.29B	4.39B	105M	1.14B
Prepaid Expenses	21.82M	50.28M	40.69M	-	10.06M
Other Current Assets, Total	765M	1.27B	765M	404M	770M
Total Current Assets	9.44B	10.76B	11.65B	6.61B	8.65B
Gross Property Plant And Equipment	13.11B	13.28B	13.39B	81.31M	5.68B
Accumulated Depreciation	-5.63B	-6.91B	-7.46B	-27.68M	-3.08B
Net Property Plant And Equipment	7.48B	6.37B	5.93B	53.64M	2.6B
Long-term Investments	355M	291M	303M	1.11B	1.74B
Goodwill	2.11M	351K	-	-	-
Other Intangibles, Total	92.01M	10M	-	-	107M
Loans Receivable Long-Term	-	-	-	3.53B	735M
Deferred Tax Assets Long-Term	604M	519M	299M	319M	446M
Other Long-Term Assets, Total	209M	56.16M	65.96M	27.87M	99.59M
Total Assets	18.18B	18.01B	18.24B	11.65B	14.38B
Liabilities
Accounts Payable, Total	1.39B	1.76B	2.04B	940M	1.1B
Accrued Expenses, Total	204M	186M	213M	99.66M	663M
Short-term Borrowings	727M	640M	492M	27.11M	55.55M
Current Portion of Long-Term Debt	480M	407M	598M	27.48M	93.51M
Current Portion of Leases	272K	270K	270K	-	154K
Current Income Taxes Payable	9.8M	53.88M	123M	1.02B	42.09M
Unearned Revenue Current, Total	253K	252K	253K	-	-
Other Current Liabilities	336M	298M	246M	101M	249M
Total Current Liabilities	3.15B	3.35B	3.71B	2.21B	2.21B
Long-Term Debt	8.84B	8.48B	7.53B	112M	257M
Long-Term Leases	4.82M	5.06M	5.32M	-	2.27M
Unearned Revenue Non Current	1.74M	1.49M	1.23M	-	74.92M
Pension & Other Post Retirement Benefits	125M	140M	148M	10.32M	91.29M
Other Non Current Liabilities	31.79M	30.24M	29.45M	1.95M	22.38M
Total Liabilities	12.15B	12B	11.42B	2.34B	2.65B
Common Stock, Total	591M	591M	591M	591M	687M
Additional Paid In Capital	3.07B	3.07B	3.07B	3.07B	3.95B
Retained Earnings	613M	738M	1.36B	5.69B	1.35B
Comprehensive Income and Other	1.76B	1.61B	1.8B	-37.77M	5.73B
Total Common Equity	6.04B	6.01B	6.82B	9.31B	11.73B
Minority Interest	-897K	-1.1M	-	-171K	-348K
Total Equity	6.03B	6.01B	6.82B	9.31B	11.73B
Total Liabilities And Equity	18.18B	18.01B	18.24B	11.65B	14.38B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	59.09M	59.09M	59.09M	59.09M	68.74M
ECS Total Common Shares Outstanding	59.09M	59.09M	59.09M	59.09M	68.74M
Book Value / Share	102.14	101.71	115.41	157.64	170.63
Tangible Book Value	5.94B	6B	6.82B	9.31B	11.62B
Tangible Book Value Per Share	100.55	101.53	115.41	157.64	169.08
Total Debt	10.05B	9.53B	8.62B	166M	409M
Net Debt	9.94B	9.32B	8.44B	-4.15B	-4.27B
Debt Equivalent of Unfunded Proj. Benefit Obligation	141M	167M	183M	-178M	105M
Debt Equivalent Oper. Leases	42.97M	41.26M	59.61M	69.11M	131M
Minority Interest, Total (Incl. Fin. Div)	-897K	-1.1M	-	-171K	-348K
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	942M	1.08B	1.08B	2.18M	817M
Inventories - Work In Process, Total	1.66B	1.91B	1.89B	-	103M
Inventories - Finished Goods, Total	1.07B	1.17B	1.28B	102M	206M
Inventories - Others	91.76M	115M	129M	-	15.86M
Land - (BS)	541M	541M	539M	-	264M
Buildings, Total	2.67B	2.69B	2.7B	-	1.37B
Machinery, Total	9.77B	9.94B	10.05B	81.31M	3.78B
Full Time Employees	1.53K	1.45K	1.5K	47	1.25K
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	526M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	-31.47M	-21.49M	476M	4.21B	2.5B
Depreciation & Amortization - CF	552M	1.3B	574M	533M	221M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	74K
Depreciation & Amortization, Total	552M	1.3B	574M	533M	221M
Amortization of Deferred Charges, Total - (CF)	321M	10.6M	-	-	23.96M
(Gain) Loss From Sale Of Asset	-	30.05M	10.61M	225M	-287M
Stock-Based Compensation (CF)	-	-	-	-	-
Provision and Write-off of Bad Debts	-	-	-	248M	16.7M
Other Operating Activities, Total	1.13B	1.06B	1.4B	-2.02B	-2.54B
Change In Accounts Receivable	-385M	-262M	-367M	-1.12B	968M
Change In Inventories	-328M	-528M	-101M	329M	-432M
Change In Income Taxes	6.4M	-	-	-	-
Change in Other Net Operating Assets	82.54M	-89.06M	-45.44M	-4.04B	-734M
Cash from Operations	1.35B	1.5B	1.95B	-1.63B	-255M
Capital Expenditure	-39.1M	-184M	-128M	-445M	-644M
Sale of Property, Plant, and Equipment	-	54.98M	1.45M	29.46M	386M
Sale (Purchase) of Intangible assets	-4.86M	-	-	-	-
Investment in Marketable and Equity Securities, Total	-62.88M	171M	-12.73M	-811M	-1.26B
Other Investing Activities, Total	5.13M	5.62M	5.31M	184M	420M
Cash from Investing	-102M	47.72M	-134M	-1.04B	-1.1B
Short Term Debt Issued, Total	-	-	-	-	276M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	276M
Long-Term Debt Repaid, Total	-399M	-360M	-459M	-374M	-66.04M
Total Debt Repaid	-399M	-360M	-459M	-374M	-66.04M
Issuance of Common Stock	-	-	-	-	926M
Other Financing Activities, Total	-839M	-1.05B	-1.4B	7.36B	-444M
Cash from Financing	-1.24B	-1.41B	-1.86B	6.99B	692M
Miscellaneous Cash Flow Adjustments	-	-	-1K	-	-
Net Change in Cash	10.29M	142M	-44.06M	4.31B	-659M
Supplemental Items
Cash Interest Paid	839M	1.05B	1.29B	1.26B	419M
Cash Income Tax Paid (Refund)	-	-	112M	728M	32.17M
Levered Free Cash Flow	245M	269M	440M	9.85B	-2.1B
Unlevered Free Cash Flow	828M	841M	980M	10.14B	-2.09B
Change In Net Working Capital	694M	863M	601M	-8.71B	1.42B
Net Debt Issued / Repaid	-399M	-360M	-459M	-374M	210M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.76	3.19	6.26	8.99	-1.89
Return on Total Capital	4.23	3.65	7.32	10.79	-2.44
Return On Equity %	-0.51	-0.36	7.42	52.18	25.24
Return on Common Equity	-0.51	-0.36	7.42	52.18	25.24
Margin Analysis
Gross Profit Margin %	50.21	49.95	46.08	49.01	48.74
SG&A Margin	11.89	10.94	11.52	12.2	22.28
EBITDA Margin %	18.32	21.13	19.64	20.68	-3.88
EBITA Margin %	12.24	8.78	14.93	16.58	-7.81
EBIT Margin %	12.24	8.78	14.93	16.58	-7.81
Income From Continuing Operations Margin %	-0.35	-0.2	3.91	32.45	44.59
Net Income Margin %	-0.35	-0.2	3.91	32.45	44.59
Net Avail. For Common Margin %	-0.35	-0.2	3.91	32.45	44.59
Normalized Net Income Margin	1.24	1.56	5.86	9.27	0.65
Levered Free Cash Flow Margin	2.7	2.56	3.62	75.91	-37.38
Unlevered Free Cash Flow Margin	9.13	7.99	8.06	78.16	-37.23
Asset Turnover
Asset Turnover	0.49	0.58	0.67	0.87	0.39
Fixed Assets Turnover	1.17	1.52	1.98	4.34	2.29
Receivables Turnover (Average Receivables)	2.15	2.34	2.51	3.8	2.35
Inventory Turnover (Average Inventory)	1.26	1.31	1.51	2.95	3.05
Short Term Liquidity
Current Ratio	3	3.22	3.14	2.99	3.92
Quick Ratio	1.56	1.54	1.48	2.76	3.05
Operating Cash Flow to Current Liabilities	0.43	0.45	0.52	-0.74	-0.12
Days Sales Outstanding (Average Receivables)	169.7	155.87	145.13	96.36	155.14
Days Outstanding Inventory (Average Inventory)	290.45	278.7	241.38	124.24	119.61
Average Days Payable Outstanding	103.27	99.14	104.16	233.71	224.59
Cash Conversion Cycle (Average Days)	356.88	335.43	282.35	-13.12	50.16
Long Term Solvency
Total Debt/Equity	166.61	158.61	126.42	1.78	3.48
Total Debt / Total Capital	62.49	61.33	55.83	1.75	3.37
LT Debt/Equity	146.6	141.18	110.44	1.2	2.21
Long-Term Debt / Total Capital	54.99	54.59	48.78	1.18	2.14
Total Liabilities / Total Assets	66.82	66.63	62.61	20.06	18.45
EBIT / Interest Expense	1.19	1.01	2.1	4.61	-31.71
EBITDA / Interest Expense	1.78	2.43	2.77	5.75	-15.75
(EBITDA - Capex) / Interest Expense	1.74	2.23	2.62	4.79	-62.32
Total Debt / EBITDA	6.05	4.29	3.61	0.06	-1.88
Net Debt / EBITDA	5.98	4.19	3.53	-1.55	19.59
Total Debt / (EBITDA - Capex)	6.2	4.67	3.81	0.07	-0.47
Net Debt / (EBITDA - Capex)	6.13	4.57	3.73	-1.86	4.95
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	13.44	16.03	15.48	6.69	-67.14
Gross Profit, 1 Yr. Growth %	13.07	15.42	8.7	13.46	-67.38
EBITDA, 1 Yr. Growth %	1.27	12.16	6.89	12.33	-107.11
EBITA, 1 Yr. Growth %	50.03	-16.72	96.4	18.46	-119.41
EBIT, 1 Yr. Growth %	50.03	-16.72	96.4	18.46	-119.42
Earnings From Cont. Operations, 1 Yr. Growth %	-85.15	-31.72	-2.31K	784.44	-53.51
Net Income, 1 Yr. Growth %	-85.15	-31.72	-2.31K	784.44	-53.51
Normalized Net Income, 1 Yr. Growth %	-190.79	45.48	335.12	68.81	-96.5
Diluted EPS Before Extra, 1 Yr. Growth %	-87.57	-31.72	-2.31K	784.38	-61.38
Accounts Receivable, 1 Yr. Growth %	9.07	5.18	11.11	-66.53	-47.43
Inventory, 1 Yr. Growth %	9.58	14.06	2.36	-97.62	53.16
Net Property, Plant and Equip., 1 Yr. Growth %	-6.31	-14.87	-6.92	-99.1	13.01
Total Assets, 1 Yr. Growth %	-2.76	-0.97	1.29	-36.13	-1.51
Tangible Book Value, 1 Yr. Growth %	-0.92	0.98	13.66	36.59	45.01
Common Equity, 1 Yr. Growth %	-5.8	-0.42	13.47	36.59	44.44
Cash From Operations, 1 Yr. Growth %	7.75	11.36	29.51	-183.81	-86.38
Capital Expenditures, 1 Yr. Growth %	-63.6	370.92	-30.65	248.59	-11.79
Levered Free Cash Flow, 1 Yr. Growth %	-0.1	10	57.48	2.14K	-122.79
Unlevered Free Cash Flow, 1 Yr. Growth %	-6.46	1.52	15.14	935.12	-121.29
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	7.89	14.73	15.8	11	-32.03
Gross Profit, 2 Yr. CAGR %	10.09	14.24	10.93	11.06	-30.1
EBITDA, 2 Yr. CAGR %	5.75	16.44	9.76	9.58	-69.81
EBITA, 2 Yr. CAGR %	57.93	11.78	27.9	52.53	-50.85
EBIT, 2 Yr. CAGR %	57.93	11.78	27.9	52.53	-50.85
Earnings From Cont. Operations, 2 Yr. CAGR %	-67.03	-68.15	288.89	1.3K	129.4
Net Income, 2 Yr. CAGR %	-67.03	-68.15	288.89	1.3K	129.4
Normalized Net Income, 2 Yr. CAGR %	-26.38	14.92	151.6	171.03	-77.4
Diluted EPS Before Extra, 2 Yr. CAGR %	-70.11	-70.86	288.89	1.3K	109.07
Accounts Receivable, 2 Yr. CAGR %	11.01	7.11	8.1	-39.02	-42.94
Inventory, 2 Yr. CAGR %	8.93	11.8	8.05	-84.38	-48.98
Net Property, Plant and Equip., 2 Yr. CAGR %	-5.9	-10.69	-10.99	-90.82	-33.76
Total Assets, 2 Yr. CAGR %	-2.78	-1.87	0.15	-19.56	-11.2
Tangible Book Value, 2 Yr. CAGR %	7.75	0.03	7.14	24.6	30.55
Common Equity, 2 Yr. CAGR %	1.33	-3.15	6.3	24.5	31.15
Cash From Operations, 2 Yr. CAGR %	44.76	9.54	20.09	4.18	-63.82
Capital Expenditures, 2 Yr. CAGR %	-49.37	30.92	80.72	55.48	124.57
Levered Free Cash Flow, 2 Yr. CAGR %	-52.7	4.83	34.09	493.94	118.54
Unlevered Free Cash Flow, 2 Yr. CAGR %	20.72	-2.55	8.77	245.24	46.1
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.29	10.54	15.01	12.68	-18.9
Gross Profit, 3 Yr. CAGR %	5.63	11.84	11.64	11.77	-19.02
EBITDA, 3 Yr. CAGR %	3.74	14.4	13.35	10.61	-53.98
EBITA, 3 Yr. CAGR %	21.32	27.59	34.89	24.68	-22
EBIT, 3 Yr. CAGR %	21.32	27.59	34.89	24.68	-22
Earnings From Cont. Operations, 3 Yr. CAGR %	-47.68	-57.97	30.97	411.41	388.48
Net Income, 3 Yr. CAGR %	-47.68	-57.97	30.97	411.41	388.48
Normalized Net Income, 3 Yr. CAGR %	-21.98	-7.61	79.12	120.26	-39.44
Diluted EPS Before Extra, 3 Yr. CAGR %	-52.2	-60.64	23.43	411.4	359.17
Accounts Receivable, 3 Yr. CAGR %	1.97	9.03	8.42	-26.87	-28.75
Inventory, 3 Yr. CAGR %	5.83	10.61	8.56	-69.69	-35.65
Net Property, Plant and Equip., 3 Yr. CAGR %	-4.7	-8.99	-9.45	-80.72	-25.81
Total Assets, 3 Yr. CAGR %	-3.49	-2.18	-0.83	-13.79	-7.22
Tangible Book Value, 3 Yr. CAGR %	11.61	5.45	4.38	16.17	24.66
Common Equity, 3 Yr. CAGR %	2.94	0.74	2.1	15.57	24.97
Cash From Operations, 3 Yr. CAGR %	22.68	32.64	15.83	6.52	-44.66
Capital Expenditures, 3 Yr. CAGR %	-42.39	6.47	5.93	124.96	51.79
Levered Free Cash Flow, 3 Yr. CAGR %	-35.12	-37.33	21.56	242.78	95.93
Unlevered Free Cash Flow, 3 Yr. CAGR %	-8.01	13.95	3.44	130.5	34.95
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	6.43	8.06	9.37	10.74	-6.81
Gross Profit, 5 Yr. CAGR %	7.91	10.29	7.72	11.1	-7.43
EBITDA, 5 Yr. CAGR %	7.05	12.62	9.93	12.55	-33.22
EBITA, 5 Yr. CAGR %	27.14	21.78	23.91	37.04	-9.93
EBIT, 5 Yr. CAGR %	27.14	21.78	23.91	37.04	-9.92
Earnings From Cont. Operations, 5 Yr. CAGR %	-44.3	-44.03	16.71	70.82	63.88
Net Income, 5 Yr. CAGR %	-44.3	-44.03	16.71	70.82	63.88
Normalized Net Income, 5 Yr. CAGR %	-23.71	-12.1	24.62	42.09	-21.75
Diluted EPS Before Extra, 5 Yr. CAGR %	-48.24	-47.59	10.56	64.23	52.39
Accounts Receivable, 5 Yr. CAGR %	3.03	4.94	4.38	-13.58	-16.13
Inventory, 5 Yr. CAGR %	1.08	4.52	6.72	-49.44	-19.74
Net Property, Plant and Equip., 5 Yr. CAGR %	-4.58	-6.54	-7.26	-63.65	-20.1
Total Assets, 5 Yr. CAGR %	-3.86	-3.37	-2.05	-9.54	-5.11
Tangible Book Value, 5 Yr. CAGR %	15.51	13.06	9.8	12.73	14.16
Common Equity, 5 Yr. CAGR %	3.13	2.49	4.27	9.64	12.86
Cash From Operations, 5 Yr. CAGR %	11.18	9.48	21.64	20.43	-27.28
Capital Expenditures, 5 Yr. CAGR %	-31.31	-1.83	-8.99	23.89	43.07
Levered Free Cash Flow, 5 Yr. CAGR %	6.25	-35.08	-13.26	55.22	53.7
Unlevered Free Cash Flow, 5 Yr. CAGR %	2.06	-21.38	-1.63	77.96	18.76